Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026)
Cooper Companies (COO) posted Non-Current Deffered Revenue of $208.8 million for Q2 2026, up 1.16% on a QoQ basis from $206.4 million in Q1 2026, and up 6.31% year-over-year from $196.4 million in Q2 2025.
Analysis
Cooper Companies (COO) Non-Current Deffered Revenue (2021 - 2026) Analysis & Trends
Cooper Companies has reported Non-Current Deffered Revenue for 6 years, with the latest figure at $208.8 million in Q2 2026.
- On a quarterly basis, Non-Current Deffered Revenue rose 6.31% year-over-year to $208.8 million in Q2 2026; TTM through Apr 2026 was $208.8 million, a 6.31% increase from a year earlier, with the FY2025 full-year figure at $201.8 million, up 4.4% from the prior year.
- Non-Current Deffered Revenue was $208.8 million for Q2 2026 at Cooper Companies, up from $206.4 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $208.8 million in Q2 2026, with the low at $182.6 million in Q2 2023.
- Average Non-Current Deffered Revenue over 5 years is $194.1 million, with a median of $193.4 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2023: Non-Current Deffered Revenue jumped 198200.0% in 2022, then dropped 7.11% in 2023.
- Over 5 years, Non-Current Deffered Revenue stood at $198.3 million in 2022, then decreased by 7.11% to $184.2 million in 2023, then increased by 4.94% to $193.3 million in 2024, then climbed by 4.4% to $201.8 million in 2025, then grew by 3.47% to $208.8 million in 2026.
- The last three Non-Current Deffered Revenue figures came in at $208.8 million (Q2 2026), $206.4 million (Q1 2026), and $201.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | - |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | - |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | - |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | - |
| 10 | Cooper Companies | 10.51 Bn | 10.37 Bn | 735.40 Mn | 208.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 208.80 Mn |
| Jan 31, 2026 | 206.40 Mn |
| Oct 31, 2025 | 201.80 Mn |
| Jul 31, 2025 | 199.40 Mn |
| Apr 30, 2025 | 196.40 Mn |
| Jan 31, 2025 | 193.40 Mn |
| Oct 31, 2024 | 193.30 Mn |
| Jul 31, 2024 | 190.80 Mn |
| Apr 30, 2024 | 188.60 Mn |
| Jan 31, 2024 | 186.30 Mn |
| Oct 31, 2023 | 184.20 Mn |
| Jul 31, 2023 | 185.50 Mn |
| Apr 30, 2023 | 182.60 Mn |
| Jan 31, 2023 | 195.10 Mn |
| Oct 31, 2022 | 198.30 Mn |
| Oct 31, 2021 | 100,000.00 |